Titanovo Logo
Back to Cell Types

YUSAC2Homo sapiens (Human)Cancer cell line

Also known as: YUSAC, YUSAC 2, YUSAC-2

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_A746
SpeciesHomo sapiens (Human)
Tissue SourceNeck, hypodermis[UBERON:UBERON_0002072]

Disease Information

DiseaseMelanoma

DepMap Information

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleBRAFp.Val600Glu (c.1799T>A)Unspecified-PubMed=26214590

Publications

Integrated analysis of tumor samples sheds light on tumor heterogeneity.

Kluger Y.

Yale J. Biol. Med. 85:347-361(2012).

PubMedPMC

Detecting copy number status and uncovering subclonal markers in heterogeneous tumor biopsies.

Xu F., Li P.-N., Halaban R., Kluger Y.

BMC Genomics 12:230.1-230.14(2011).

DOIPubMedPMC

PLX4032, a selective BRAF(V600E) kinase inhibitor, activates the ERK pathway and enhances cell migration and proliferation of BRAF melanoma cells.

Krauthammer M., McCusker J.P., Kluger Y., Sznol M.

Pigment Cell Melanoma Res. 23:190-200(2010).

DOIPubMedPMC

Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells.

Setaluri V., Hebert D.N.

Proc. Natl. Acad. Sci. U.S.A. 94:6210-6215(1997).

DOIPubMedPMC